Insider track record
OtherAcross 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Onyia Jude. Officer active across 1 company, notably Neurocrine Biosciences INC. Aggregated, 10 reports have been published. Split: 0 buy · 7 sells. Total volume traded: €1.5m. History available since 29 November 2022. The latest transaction was filed on 13 February 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
2,717 shares0Common StockSEC:0000914475-25-000067:0
238 shares0Common StockSEC:0000914475-25-000027:0
4,426 shares0Common StockSEC:0000914475-24-000222:0
1,432 shares@ US$132.940712.1% of flowCommon StockSEC:0000914475-24-000075:0
126 shares@ US$141.941.1% of flowCommon StockSEC:0000914475-24-000030:0
2,331 shares@ US$113.570516.4% of flowCommon StockSEC:0001209191-23-057097:0
3,198 shares@ US$107.369621.5% of flowCommon StockSEC:0001209191-23-047139:0
4,508 shares@ US$102.299529.3% of flowCommon StockSEC:0001209191-23-007915:0
126 shares@ US$108.480.9% of flowCommon StockSEC:0001209191-23-006281:0
2,331 shares@ US$121.904818.7% of flowCommon StockSEC:0001209191-22-059242:0